Comments on: Lancet retracts COOPERATE trial of dual RAS inhibition and spanks lead author for serious misconduct http://cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/ One-stop source for cardiology news and links Thu, 09 Sep 2010 21:23:40 +0000 hourly 1 http://wordpress.com/ By: Cardiac stuff, hypertension and good science « Blue Lyon http://cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/#comment-3203 Cardiac stuff, hypertension and good science « Blue Lyon Sun, 14 Mar 2010 19:31:49 +0000 http://cardiobrief.org/?p=3418#comment-3203 [...] Lancet retracts COOPERATE trial of dual RAS inhibition and spanks lead author for serious misconduc... The Lancet has published a retraction of COOPERATE (Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease) and reported that its lead author, Naoyuki Nakao, appears to have engaged in serious scientific misconduct. [...] [...] Lancet retracts COOPERATE trial of dual RAS inhibition and spanks lead author for serious misconduc… The Lancet has published a retraction of COOPERATE (Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease) and reported that its lead author, Naoyuki Nakao, appears to have engaged in serious scientific misconduct. [...]

]]> By: Marilyn Mann http://cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/#comment-2073 Marilyn Mann Fri, 09 Oct 2009 00:16:13 +0000 http://cardiobrief.org/?p=3418#comment-2073 Whoa. Whoa.

]]>